index - CRCL-Mort cellulaire et cancers pédiatriques

Clara Savary, Léa Luciana, Paul Huchedé, Arthur Tourbez, Claire Coquet, et al.. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers. Cell Reports Medicine, 2023, 4, ⟨10.1016/j.xcrm.2023.101339⟩. ⟨hal-04374201⟩
Cyril Malinet, Bruno Montcel, Aurélie Dutour, Iveta Fajnorova, Herve Liebgott, et al.. Cancer characterization using light backscattering spectroscopy and quantitative ultrasound: an ex vivo study on sarcoma subtypes. Scientific Reports, 2023, 13 (1), pp.16650. ⟨10.1038/s41598-023-43322-4⟩. ⟨hal-04251451⟩
Paul Huchedé, Swann Meyer, Clément Berthelot, Maud Hamadou, Adrien Bertrand-Chapel, et al.. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas. 2023. ⟨hal-04295430⟩
Benoît Allignet, Alexis Vallard, Jacqueline M Deloumeaux, Oleksandr Ogorodniitchouk, Sébastien Mourey, et al.. Etat des lieux des essais cliniques en cancérologie : Inégalités entre France hexagonale et départements ultramarins. Séminaire Unicancer de Cancérologie Outre-Mer, Nov 2023, Paris, France. ⟨hal-04299514⟩
Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, et al.. The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma. Life Science Alliance, 2023, 6 (12), pp.e202302200. ⟨10.26508/lsa.202302200⟩. ⟨hal-04374222⟩
Arthur Bassot, Helena Dragic, Sarah Al Haddad, Laurine Moindrot, Soline Odouard, et al.. Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. Cell Death and Disease, 2023, 14, ⟨10.1038/s41419-023-06117-z⟩. ⟨hal-04231610⟩

Derniers manuscrits de l'équipe

Chiffres clés